Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?

Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?

Item
http://www.wikidata.org/entity/Q36098819
Papillary carcinoma of the breast: an overview.CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomasChallenging breast lesions: pitfalls and limitations of fine-needle aspiration and the role of core biopsy in specific lesions.Surgical excision of intraductal breast papilloma diagnosed on core biopsy.Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012.Pathological criteria and practical issues in papillary lesions of the breast - a review.Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.Papillary lesions of the breast diagnosed using core needle biopsies.Keratin expression in breast cancers.Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note.Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats.Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast
P2860

Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?

Item
http://www.wikidata.org/entity/Q36098819
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@ast
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@en
type
label
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@ast
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@en
prefLabel
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@ast
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Cytokeratins in papillary lesi ...... lary ductal carcinoma in situ?
@en
P2093
P304
P31
P356
10.1097/01.PAS.0000157941.88161.39
P407
P433
P478
P577
P698